Securities Class Action Lawsuit Filed Against Reckitt Benckiser Group plc

Levi & Korsinsky, LLP has notified investors in Reckitt Benckiser Group plc of a class action securities lawsuit, seeking to recover losses on behalf of investors who were adversely affected by alleged securities fraud between January 13, 2021, and July 28, 2024. The lawsuit alleges that defendants made false statements and/or concealed the increased risk of Necrotizing Enterocolitis (NEC) in preterm infants due to consuming Reckitt's cow's milk-based formula, Enfamil, which had a negative impact on the company's sales and exposure to legal claims.

Key Takeaways:

• The lawsuit alleges that Reckitt Benckiser Group plc made false statements and/or concealed the increased risk of NEC in preterm infants due to consuming Enfamil.
• The class action seeks to recover losses on behalf of investors who were affected by the alleged securities fraud between January 13, 2021, and July 28, 2024.
• The lead plaintiffs have until August 4, 2025, to request that the Court appoint them as lead plaintiff.
• There is no cost or obligation to participate in the lawsuit for class members.
• Levi & Korsinsky, LLP has secured hundreds of millions of dollars for aggrieved shareholders and has a track record of winning high-stakes cases.

Statistics:

• The alleged securities fraud took place between January 13, 2021, and July 28, 2024.
• The lawsuit seeks to recover losses on behalf of investors who were affected by the alleged securities fraud.
• Levi & Korsinsky, LLP has a team of over 70 employees serving their clients.
• The firm has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States for seven consecutive years.

Sources:

• GlobeNewswire, "Levi & Korsinsky, LLP Notifies Investors in Reckitt Benckiser Group plc (OTC PINK: RBGLY) of Class Action Securities Lawsuit", July 14, 2025
• COMTEX_467326949/2010/2025-07-14T16:26:00